X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (31862) 31862
Publication (2142) 2142
Newspaper Article (1948) 1948
Newsletter (1923) 1923
Book Review (563) 563
Book Chapter (229) 229
Magazine Article (123) 123
Trade Publication Article (68) 68
Conference Proceeding (48) 48
Transcript (42) 42
Book / eBook (36) 36
Dissertation (35) 35
Web Resource (13) 13
Reference (10) 10
Paper (5) 5
Data Set (3) 3
Report (3) 3
Government Document (1) 1
Journal / eJournal (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (20434) 20434
anticoagulants (18476) 18476
index medicus (13008) 13008
male (9336) 9336
female (8937) 8937
anticoagulants - therapeutic use (6764) 6764
animals (6572) 6572
hematology (5742) 5742
middle aged (5465) 5465
thrombosis (4798) 4798
adult (4781) 4781
aged (4675) 4675
anticoagulants - pharmacology (4345) 4345
peripheral vascular disease (4240) 4240
heparin (4060) 4060
anticoagulants - administration & dosage (3599) 3599
warfarin (3374) 3374
analysis (3300) 3300
risk factors (3264) 3264
thrombin (3050) 3050
glycosaminoglycans (3031) 3031
pharmacology & pharmacy (3000) 3000
anticoagulants - adverse effects (2968) 2968
anticoagulant (2932) 2932
research (2847) 2847
thromboembolism (2713) 2713
cardiac & cardiovascular systems (2375) 2375
coagulation (2301) 2301
surgery (2301) 2301
stroke (2259) 2259
treatment outcome (2238) 2238
blood coagulation - drug effects (2199) 2199
care and treatment (2133) 2133
biochemistry & molecular biology (2116) 2116
prevention (2068) 2068
venous thromboembolism (2062) 2062
health aspects (1892) 1892
medicine & public health (1887) 1887
drug therapy (1874) 1874
proteins (1864) 1864
anticoagulation (1819) 1819
atrial fibrillation (1800) 1800
aged, 80 and over (1783) 1783
rats (1735) 1735
patients (1728) 1728
blood (1700) 1700
molecular-weight heparin (1687) 1687
therapy (1679) 1679
time factors (1610) 1610
mice (1578) 1578
administration, oral (1575) 1575
dose-response relationship, drug (1561) 1561
risk (1555) 1555
anticoagulant activity (1528) 1528
heparin - pharmacology (1515) 1515
pregnancy (1471) 1471
mortality (1412) 1412
heparin - therapeutic use (1405) 1405
anticoagulants - chemistry (1394) 1394
medicine, general & internal (1349) 1349
plasma (1332) 1332
management (1310) 1310
adolescent (1288) 1288
cardiology (1266) 1266
rivaroxaban (1241) 1241
partial thromboplastin time (1238) 1238
retrospective studies (1212) 1212
prospective studies (1204) 1204
warfarin - therapeutic use (1199) 1199
medicine (1193) 1193
factor xa inhibitors (1190) 1190
medical research (1190) 1190
dabigatran (1189) 1189
hemorrhage - chemically induced (1173) 1173
venous thrombosis (1150) 1150
cancer (1139) 1139
studies (1126) 1126
sulfates (1107) 1107
deep-vein thrombosis (1106) 1106
in-vitro (1079) 1079
unfractionated heparin (1057) 1057
dosage and administration (1053) 1053
anticoagulants - pharmacokinetics (1044) 1044
aspirin (1044) 1044
internal medicine (1042) 1042
blood coagulation (1039) 1039
abridged index medicus (1034) 1034
molecular weight (1033) 1033
blood clot (1027) 1027
enzymes (1026) 1026
diagnosis (1024) 1024
disease (1017) 1017
activation (1006) 1006
article (1001) 1001
clinical trials (999) 999
pharmacokinetics (994) 994
prothrombin time (993) 993
cardiac arrhythmia (992) 992
international normalized ratio (988) 988
drugs (970) 970
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (35383) 35383
Russian (163) 163
French (148) 148
German (145) 145
Japanese (98) 98
Spanish (72) 72
Chinese (61) 61
Italian (43) 43
Portuguese (28) 28
Polish (19) 19
Korean (16) 16
Hungarian (9) 9
Czech (8) 8
Turkish (7) 7
Dutch (6) 6
Bulgarian (3) 3
Danish (3) 3
Norwegian (3) 3
Ukrainian (3) 3
Croatian (2) 2
Serbian (2) 2
Swedish (2) 2
Arabic (1) 1
Estonian (1) 1
Lithuanian (1) 1
Romanian (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 06/2010, Volume 103, Issue 6, pp. 1116 - 1127
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 25, pp. 2413 - 2424
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 11, pp. 1128 - 1139
Abstract Background Non–vitamin K oral anticoagulants (NOACs) do not require routine laboratory monitoring. However, laboratory measurement may be desirable in... 
Cardiovascular | Internal Medicine | dabigatran | rivaroxaban | monitoring | laboratory | apixaban | MEASURING RIVAROXABAN | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | DABIGATRAN CONCENTRATIONS | PROTHROMBIN TIME | PARTIAL THROMBOPLASTIN TIME | COAGULATION ASSAYS | IN-VITRO | FACTOR-XA INHIBITOR | PLASMA-CONCENTRATIONS | INTERNATIONAL NORMALIZED RATIO | Anticoagulants - administration & dosage | Humans | Antithrombins - administration & dosage | Thiophenes - administration & dosage | Dabigatran | Factor Xa Inhibitors - administration & dosage | Antithrombins - pharmacology | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | beta-Alanine - pharmacology | Factor Xa Inhibitors - pharmacology | beta-Alanine - analogs & derivatives | Pyrazoles - pharmacology | Administration, Oral | Morpholines - administration & dosage | beta-Alanine - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Pyrazoles - administration & dosage | Partial Thromboplastin Time | Anticoagulants - pharmacology | Benzimidazoles - pharmacology | Drug Monitoring | Pyridones - pharmacology | Measurement | Anticoagulants (Medicine) | Vitamins | Studies | Anticoagulants | Plasma | Bibliographic literature | Laboratories | Drug therapy | Drug dosages | Bone surgery
Journal Article
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 05/2007, Volume 282, Issue 20, pp. 14984 - 14991
Heparin is an excellent inhibitor of P- and L-selectin binding to the carbohydrate determinant, sialyl Lewisx. As a consequence of its anti-selectin activity,... 
CARCINOMA MUCINS | LIGANDS | BIOCHEMISTRY & MOLECULAR BIOLOGY | IN-VIVO | P-SELECTIN | LUNG COLONIZATION | CELL-ADHESION | COLON | HEPARIN | CANCER | PLATELET-AGGREGATING ACTIVITIES | Sea Cucumbers - chemistry | Lung Neoplasms - drug therapy | Adenocarcinoma - pathology | P-Selectin - metabolism | Lung Neoplasms - metabolism | Pneumonia - pathology | Heparin - therapeutic use | Lung Neoplasms - pathology | Thioglycolates - toxicity | L-Selectin - metabolism | Dose-Response Relationship, Drug | Neoplasms, Experimental - pathology | Peritonitis - pathology | Neoplasm Metastasis | Adenocarcinoma - metabolism | Lung Neoplasms - secondary | Pneumonia - chemically induced | Heparin - pharmacology | Neutrophil Infiltration - drug effects | Disease Models, Animal | Lipopolysaccharides - toxicity | Peritonitis - metabolism | Anticoagulants - therapeutic use | Chondroitin Sulfates - pharmacology | Peritonitis - chemically induced | Chondroitin Sulfates - chemistry | Cell Adhesion - drug effects | Chondroitin Sulfates - therapeutic use | Adenocarcinoma - drug therapy | Animals | Pneumonia - drug therapy | Partial Thromboplastin Time | Anticoagulants - pharmacology | Mice | Neoplasms, Experimental - metabolism | Peritonitis - drug therapy | Carbohydrate Conformation | Pneumonia - metabolism | Neoplasms, Experimental - drug therapy
Journal Article